Form 4: VolitionRX Director Kim Nguyen Reports Acquisition of Shares in Lieu of Cash Compensation

Sentiment:

SEC Form 4 Filing


Director Kim Nguyen acquired 9,171 shares of VolitionRX Ltd. in lieu of cash compensation on September 1, 2024.

Summary

  • On September 1, 2024, Kim Nguyen, a director of VolitionRX Ltd., acquired 9,171 shares of common stock.
  • These shares were awarded as restricted stock units (RSUs) under the company's 2015 Stock Incentive Plan.
  • The RSUs were granted in lieu of cash compensation that would have otherwise been owed to Nguyen.
  • The RSUs vest in three equal installments of 3,057 units on September 1, 2024, October 1, 2024, and November 1, 2024.
  • The RSUs are also subject to further time-based vesting in a single installment on June 1, 2025, contingent upon continued service.
  • Upon vesting and settlement, Nguyen will receive common stock equal to the number of vested RSUs.
  • Nguyen also indirectly owns 30,556 shares through their spouse.
  • Following the reported transaction, Nguyen directly owns 67,868 shares of VolitionRX Ltd.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. A director receiving stock in lieu of cash is generally a good sign, aligning interests with shareholders. The vesting schedule also promotes long-term commitment.

Positives

  • A director taking compensation in stock aligns their interests with shareholders.
  • The vesting schedule incentivizes continued service by the director.

Future Outlook

The director's future ownership will increase as the RSUs vest, contingent on continued service.

Industry Context

Directors receiving stock-based compensation is a common practice to align management's interests with those of shareholders, particularly in growth-oriented companies.

Comparison to Industry Standards

  • Stock-based compensation for directors is a common practice across various industries, especially in biotech and technology companies.
  • Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals often use stock options and RSUs as part of their director compensation packages.
  • The vesting schedules and amounts typically vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

  • Shareholders may view this positively as it aligns the director's interests with the company's performance.
  • The director is incentivized to contribute to the company's success to increase the value of their stock holdings.

Key Dates

DateDescription
09/01/2024Date of earliest transaction: Acquisition of 9,171 RSUs and first vesting installment of 3,057 units.
10/01/2024Second vesting installment of 3,057 units.
11/01/2024Third vesting installment of 3,057 units.
06/01/2025Final vesting installment of RSUs.
09/04/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.